1. ADHD pharmacotherapy and real-world outcomes: emulation of target trials using nationwide register data. BMJ. 2025. (IF: 93.7,中科院一区,Top期刊,第一作者)
2. ADHD medications and long-term risk of cardiovascular diseases: a nationwide nested case-control study in Sweden. JAMA Psychiatry. 2024; 81(2):178–187. (IF: 25.9,中科院一区,Top期刊,第一作者 & 共同通讯作者)
3. Attention-deficit/hyperactivity disorder and Alzheimer's disease and any dementia: a multi-generation cohort study in Sweden. Alzheimer’s & Dementia. 2022; 18(6):1155–1163. (IF: 21.5,中科院一区,Top期刊,第一作者 & 共同通讯作者)
4. Public mobility and social media attention in response to COVID-19 in Sweden and Denmark. JAMA Network Open. 2021; 4(1):e2033478. (IF: 13.8,中科院一区,Top期刊,第一作者)
5. Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. JAMA Network Open. 2022; 5(11):e2243597. (IF: 13.8,中科院一区,Top期刊,共同第一作者 & 共同通讯作者)
用户登录
还没有账号?
立即注册